Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-25-000661
Filing Date
2025-02-14
Accepted
2025-02-14 16:33:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7952
2 jfa.htm EX-1 5847
  Complete submission text file 0000905148-25-000661.txt   15504
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92700 | Film No.: 25629819
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 855 BOYLSTON STREET 10TH FLOOR BOSTON MA 02116
Business Address 855 BOYLSTON STREET 10TH FLOOR BOSTON MA 02116 857-201-5983
K2 HealthVentures Equity Trust LLC (Filed by) CIK: 0001948604 (see all company filings)

EIN.: 842128131 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A